CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 147,218	$ 99,216
Marketable securities	21,536	15,000
Research and development incentive receivable	854	562
Inventory	831	0
Prepaid expenses and other current assets	4,977	7,298
Total current assets	175,416	122,076
Property and equipment, net	808	745
Goodwill	17,351	17,351
Finite-Lived Intangible Assets, Net	10,375	0
Right-of-use assets	4,872	5,650
Other assets	1,789	1,436
Total assets	210,611	147,258
Current liabilities:
Accounts payable	7,986	8,947
Accrued expenses (Note 9)	19,744	12,816
Current portion of lease liability	1,172	1,099
Total current liabilities	28,902	22,862
Long-term debt, including accretion, net of discount	75,030	54,570
Lease liabilities	2,026	2,612
Warrant liability (Note 5)	9,223	15,683
Other liabilities	979	432
Total liabilities	116,160	96,159
Commitments and contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.001 par value, 500,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; 168,196,180 and 167,434,595 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively	168	167
Additional paid-in capital	533,280	528,956
Accumulated other comprehensive loss	(159)	(119)
Accumulated deficit	(438,838)	(477,905)
Total stockholders’ equity	94,451	51,099
Total liabilities and stockholders’ equity	$ 210,611	$ 147,258